Glenview Capital Management Sells $71 Million of Alight Stake After Stock's 71% Drop

Glenview Capital Management, LLC cut its stake in Alight, Inc.(NYSE:ALIT) by 4,004,556 shares in the third quarter, reducing exposure by an estimated $71.57 million, according to a November 14, 2025, ...

Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC Filing

Glenview Capital Management, LLC increased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 868,457 ...

CVS Health Is Seeing Margin And App Momentum, Analyst Highlights

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health Corporation (CVS) sees higher price target despite PBM pressures

CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein ...
Secondaries Investor

CVs unlikely to ‘disappear’ because GPs ‘recognise their viability’ – TPG

While TPG has been active as a buyer on the CV market, Schilling told Buyouts that the firm is less active when it comes to ...